The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes
Open accessAbstract
Monocytes play a central role in the immunopathological effects of sepsis. This role is mediated by production of the cytokines TNF-α and IL-1β. The transcription factor NF-E2-related factor 2 (Nrf2) regulates innate immune responses in various experimental disease models. Presently, the role of Nrf2-regulated genes in LPS-treated human monocytes is not well defined. Herein we show that Nrf2 mediates a significant regulation of LPS-induced inflammatory responses. Analysis of Nrf2-regulated gene expression in human monocytes showed that LPS induced the expression of the phase II detoxification gene NAD(P)H:quinone oxidoreductase 1 (NQO1). Furthermore, NQO1 mRNA or protein expression in response to LPS was regulated by Nrf2. Silencing Nrf2 expression in human monocytes inhibited LPS-induced NQO1 expression; however, in contrast, it significantly increased TNF and IL-1β production. Silencing expression of NQO1 alone, or in combination with heme oxygenase-1 (HO-1) silencing, markedly increased LPS-induced TNF and IL-1β expression. Additionally, overexpression of NQO1 and/or HO-1 inhibited LPS-induced TNF and IL-1β expression. These results show for the first time that LPS induces NQO1 and HO-1 expression in human monocytes via Nrf2 to modulate their inflammatory responsiveness, thus providing novel potential therapeutic strategies for the treatment of sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nrf2 plays a role in regulating the anti-inflammatory response through redox control and activation of ARE-mediated anti-inflammatory genes, including the expression of the antioxidant genes NQO1, HO-1, and PRX1, all of which exhibit anti-inflammatory effects [191,192,193,194].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,730
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration
Mogensen, C. E. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076979 · Cited by 2,654
The Prevalence of Nosocomial Infection in Intensive Care Units in Europe
Vincent, J. (1995) · JAMA · doi:10.1001/jama.274.8.639 · Cited by 2,592
LPS induction of gene expression in human monocytes
Guha, M., & Mackman, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00149-2 · Cited by 2,333
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,473
Cited by
Sorted by citations
Transcriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,280
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova‐Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,210
NRF2, a Transcription Factor for Stress Response and Beyond
He, F., Ru, X., & Wen, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134777 · Cited by 1,820
An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
Saha, S., Buttari, B., Panieri, E., Profumo, E., & Saso, L. (2020) · Molecules · doi:10.3390/molecules25225474 · Cited by 1,460
Role of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Reactive Oxygen Species: Drivers of Physiological and Pathological Processes
Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 1,060
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
When NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595
Nrf2 in cancers: A double‐edged sword
Wu, S., Lu, H., & Bai, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2101 · Cited by 479
Proteasomal Degradation Is Transcriptionally Controlled by TCF11 via an ERAD-Dependent Feedback Loop
Steffen, J., Seeger, M., Koch, A., & Krüger, E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.012 · Cited by 366
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
Gao, W., Guo, L., Yang, Y., Wang, Y., Xia, S., Gong, H., Zhang, B., & Yan, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809952 · Cited by 358
NRF2 as a regulator of cell metabolism and inflammation in cancer
He, F., Antonucci, L., & Karin, M. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa039 · Cited by 332
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 323
Rushworth, S. A., Zaitseva, L., Murray, M. Y., Shah, N. M., Bowles, K. M., & MacEwan, D. J. (2012) · Blood · doi:10.1182/blood-2012-04-422121 · Cited by 290
Self-citationAncuța, P., Liu, K., Misra, V., Wacleche, V. S., Gosselin, A., Zhou, X., & Gabuzda, D. H. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-403 · Cited by 284
Thirty years of NRF2: advances and therapeutic challenges.
Zhang, D. D. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01145-0 · Cited by 282
A review on heme oxygenase-1 induction: is it a necessary evil
Waza, A. A., Hamid, Z., Ali, S., Bhat, S. A., & Bhat, M. A. (2018) · Inflammation Research · doi:10.1007/s00011-018-1151-x · Cited by 243
Nrf2: A Potential Target for New Therapeutics in Liver Disease
Bataille, A. M., & Manautou, J. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.110 · Cited by 230
Harada, N., Kanayama, M., Maruyama, A., Yoshida, A., Tazumi, K., Hosoya, T., Mimura, J., Toki, T., Maher, J. M., Yamamoto, M. P., et al. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.001 · Cited by 236
Molecular and cellular paradigms of multidrug resistance in cancer
Vaidya, F. U., Chhipa, A. S., Mishra, V., Gupta, V. K., Rawat, S. G., Kumar, A., & Pathak, C. (2020) · Cancer Reports · doi:10.1002/cnr2.1291 · Cited by 215
Kong, X., Thimmulappa, R. K., Kombairaju, P., & Biswal, S. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902315 · Cited by 195
Potential Applications of NRF2 Inhibitors in Cancer Therapy
Panieri, E., & Saso, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8592348 · Cited by 189
Kundu, J. K., & Surh, Y. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0096-8 · Cited by 171
Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
Choi, B.-H., Kang, K.-S., & Kwak, M. (2014) · Molecules · doi:10.3390/molecules190812727 · Cited by 164
Goh, J. X. H., Tan, L. T., Goh, J. K., Chan, K., Pusparajah, P., Lee, L., & Goh, B. H. (2019) · Cancers · doi:10.3390/cancers11060867 · Cited by 152
Wei, Y., Gong, J., Yoshida, T., Eberhart, C. G., Xu, Z., Kombairaju, P., Sporn, M. B., Handa, J. T., & Duh, E. J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.026 · Cited by 143
Park, J., Shin, J. A., Jung, J.-S., Hyun, J., Le, T. K. V., Kim, D., Park, E., & Kim, H.-S. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189035 · Cited by 142
Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities
Irwin, M. E., Valle, N. R.-D., & Chandra, J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4258 · Cited by 146
Yeligar, S. M., Machida, K., & Kalra, V. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138636 · Cited by 140
Cunnington, A. J., Njie, M., Correa, S., Takem, E. N., Riley, E. M., & Walther, M. R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201028 · Cited by 126
Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction
Steel, R., Cowan, J., Payerne, E., O'Connell, M. A., & Searcey, M. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300041g · Cited by 113
Self-citationAl-Bakheet, S. A., Attafi, I. M., Maayah, Z. H., Abd‐Allah, A. R. A., Asiri, Y. A., & Korashy, H. M. (2013) · Environmental Pollution · doi:10.1016/j.envpol.2013.06.014 · Cited by 99
Kawakami, R., Katsuki, S., Travers, R. J., Romero, D., BECKER-GREENE, D. R., Passos, L. S. A., Higashi, H., Blaser, M. C., Sukhova, G. K., Buttigieg, J. A., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.314087 · Cited by 105
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Jung, B.-J., Yoo, H.-S., Shin, S., Park, Y., & Jeon, S. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.195 · Cited by 104
Liu, M.-W., Su, M.-X., Tang, D.-Y., Hao, L., Xun, X.-H., & Huang, Y.-Q. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0799-5 · Cited by 94
Jiang, Z., Xu, L., Lu, M., Chen, Z., Yuan, Z., Xu, X., Guo, X., Zhang, X., Sun, H.-P., & You, Q. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00185 · Cited by 94
Rushworth, S. A., Bowles, K. M., & MacEwan, D. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3018 · Cited by 92
Self-citationMarburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1
Page, A., Volchkova, V. A., Reid, S. P., Mateo, M., Bagnaud-Baule, A., Nemirov, K., Shurtleff, A. C., Lawrence, P., Reynard, O., Ottmann, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.027 · Cited by 91
Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia
Zhou, F., Shen, Q., & Claret, F. X. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113006 · Cited by 93
Cheng, S.-E., Lee, I.-T., Lin, C.-C., Kou, Y. R., & Yang, C.-M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.026 · Cited by 86
Wu, X., Song, M., Gao, Z., Sun, Y., Wang, M., Li, F., Zheng, J., & Xiao, H. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.12.020 · Cited by 84
Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma
Raninga, P. V., Trapani, G. D., Vučković, S., Bhatia, M., & Tonissen, K. F. (2015) · Oncotarget · doi:10.18632/oncotarget.3795 · Cited by 83
Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 86
Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
Luo, M., & Wicha, M. S. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.003 · Cited by 81
Cerebrovascular and Neurological Disorders: Protective Role of NRF2
Sivandzade, F., Bhalerao, A., & Cucullo, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143433 · Cited by 79
Nrf2 is a critical modulator of the innate immune response in a model of uveitis
Nagai, N., Thimmulappa, R. K., Cano, M., Fujihara, M., Izumi‐Nagai, K., Kong, X., Sporn, M. B., Kensler, T. W., Biswal, S. S., & Handa, J. T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.04.033 · Cited by 79
Miyazaki, T., Kirino, Y., Takeno, M., Samukawa, S., Hama, M., Tanaka, M., Yamaji, S., Ueda, A., Tomita, N., Fujita, H., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01550.x · Cited by 79
TNF Mediates the Sustained Activation of Nrf2 in Human Monocytes
Rushworth, S. A., Shah, S., & MacEwan, D. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004117 · Cited by 80
Self-citationHeasman, S.-A., Zaitseva, L., Bowles, K. M., Rushworth, S. A., & MacEwan, D. J. (2011) · Oncotarget · doi:10.18632/oncotarget.321 · Cited by 77
Self-citationKolamunne, R. T., Dias, I. H. K., Vernallis, A. B., Grant, M. M., & Griffiths, H. R. (2013) · Redox Biology · doi:10.1016/j.redox.2013.08.002 · Cited by 76
Kriegenburg, F., Poulsen, E. G., Koch, A., Krüger, E., & Hartmann‐Petersen, R. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3590 · Cited by 77
Oxidative Stress Responses and NRF2 in Human Leukaemia
Abdul-Aziz, A. M., MacEwan, D. J., Bowles, K. M., & Rushworth, S. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/454659 · Cited by 73
Self-citationMohammadi, G., Karimi, A. A., Hafezieh, M., Dawood, M. A. O., & Abo‐Al‐Ela, H. G. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.12.042 · Cited by 70
Gamma-oryzanol Prevents LPS-induced Brain Inflammation and Cognitive Impairment in Adult Mice
Mastinu, A., Bonini, S. A., Rungratanawanich, W., Aria, F., Marziano, M., Maccarinelli, G., Abate, G., Premoli, M., Memo, M., & Uberti, D. L. (2019) · Nutrients · doi:10.3390/nu11040728 · Cited by 72
Bathish, B., Robertson, H., Dillon, J. F., Dinkova‐Kostova, A. T., & Hayes, J. D. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.226 · Cited by 68
Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation
Li, J., Wang, H., Zheng, Z.-H., Luo, L., Wang, P., Liu, K., Namani, A., Jiang, Z., Wang, X. J., & Tang, X. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.002 · Cited by 67
Anti-inflammatory effects of 4′-demethylnobiletin, a major metabolite of nobiletin
Wu, X., Song, M., Rakariyatham, K., Zheng, J., Guo, S., Tang, Z., Zhou, S., & Xiao, H. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.09.035 · Cited by 65
The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
Rushworth, S. A., & MacEwan, D. J. (2011) · Cancers · doi:10.3390/cancers3021605 · Cited by 63
Self-citationFlavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
Vargas-Mendoza, N., Morales‐González, Á., Morales-Martínez, M., Soriano-Ursua, M. A., Delgado‐Olivares, L., Sandoval-Gallegos, E. M., Madrigal‐Bujaidar, E., Álvarez‐González, I., Madrigal‐Santillán, E., & Morales‐González, J. A. (2020) · Biomedicines · doi:10.3390/biomedicines8050122 · Cited by 66
Cao, Z., Gao, J., Huang, W., Yan, J., Shan, A., & Gao, X. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113281 · Cited by 63
Rushworth, S. A., Bowles, K. M., Raninga, P. V., & MacEwan, D. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3407 · Cited by 62
Self-citationThapa, D., Meng, P., Bedolla, R. G., Reddick, R. L., Kumar, A. P., & Ghosh, R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0562 · Cited by 62
Ginseng: a promising neuroprotective strategy in stroke
Rastogi, V., Santiago‐Moreno, J., & Doré, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00457 · Cited by 61
Reddy, P. V. B., Gandhi, N. H., Samikkannu, T., Saiyed, Z. M., Agudelo, M., Yndart, A., Khatavkar, P., & Nair, M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.06.011 · Cited by 59
Wang, Y., Wang, H., Qian, C., Tang, J., Zhou, W., Liu, X., You, Q., & Hu, R. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.11.015 · Cited by 59
NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation
Kimura, A., Kitajima, M., Nishida, K., Serada, S., Fujimoto, M., Naka, T., Fujii‐Kuriyama, Y., Sakamato, S., Ito, T., Handa, H., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172024 · Cited by 58
Kim, N., Oh, M., Park, H., & Kim, I. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09330fp · Cited by 56
The role of Nrf2 in protection against Pb-induced oxidative stress and apoptosis in SH-SY5Y cells
Ye, F., Li, X., Li, L., Lyu, L., Yuan, J., & Chen, J. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.10.009 · Cited by 55
Kim, H., Jung, Y., Shin, B. S., Kim, H., Song, H., Bae, S. H., Rhee, S. G., & Jeong, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126839 · Cited by 56
Yang, H., Lin, S.-W., Lee, C.-C., Lin, K., Liao, C.-H., Yang, T., Wang, H., Huang, H., Wu, C., & Hseu, Y. (2014) · Food & Function · doi:10.1039/c4fo00869c · Cited by 53
Funakoshi‐Tago, M., Nonaka, Y., Tago, K., Takeda, M., Ishihara, Y., Sakai, A., Matsutaka, M., Kobata, K., & Tamura, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-59380-x · Cited by 53
HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease
Liu, Y., Jing, F., Yi, W., Mendelson, A., Shi, P., Walsh, R., Friedman, D. F., Minniti, C., Manwani, D., Chou, S. T., et al. (2018) · Blood · doi:10.1182/blood-2017-12-819870 · Cited by 51
Lee, J. A., Kim, J. H., Woo, S. Y., Son, H. J., Han, S. H., Jang, B. K., Choi, J. W., Kim, D. J., Park, K. D., & Hwang, O. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12973 · Cited by 50
PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis
LIU, Y., Liu, H., Huiqin, C., Song, B., ZHANG, W., & Zhang, W. (2015) · Oncology Reports · doi:10.3892/or.2015.4308 · Cited by 49
The functional role of sulforaphane in intestinal inflammation: a review
Wei, L., Zhang, J., Zheng, L., & Chen, Y. (2021) · Food & Function · doi:10.1039/d1fo03398k · Cited by 48
Park, S. Y., Park, S. J., Park, T. G., Seetharaman, R., Lee, S.-J., & Choi, Y. W. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.032 · Cited by 48
Liu, Y., Zhong, H., Bao, W., Mendelson, A., An, X., Shi, P. A., Chou, S. T., Manwani, D. G., & Yazdanbakhsh, K. (2019) · Blood · doi:10.1182/blood.2019000172 · Cited by 51
Huang, J., Shen, X., Yue, S., Zhu, J., Gao, F., Zhai, Y., Busuttil, R. W., Ke, B., & Kupiec‐Weglinski, J. W. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00103 · Cited by 48
Bayele, H. K., Balesaria, S., & Srai, S. K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.001 · Cited by 47
Singh, V., Prakhar, P., Rajmani, R. S., Mahadik, K., Borbora, S. M., & Balaji, K. N. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix322 · Cited by 49
Wang, L., Wang, X., Kong, L., Wang, S., Huang, K., Wu, J., Wang, C., Sun, H., Liu, K., & Meng, Q. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108159 · Cited by 46
Liu, M., Liu, R., Wu, H., Li, Y., Su, M.-X., Dong, M.-N., Zhang, W., & Qian, C. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-0991-6 · Cited by 45
Nrf2 as a master regulator of tissue damage control and disease tolerance to infection
Soares, M. P., & Ribeiro, A. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150054 · Cited by 46
The molecular biology and therapeutic potential of Nrf2 in leukemia
Khodakarami, A., Adibfar, S., Karpisheh, V., Abolhasani, S., Jalali, P., Mohammadi, H., Navashenaq, J. G., Hojjat‐Farsangi, M., & Jadidi‐Niaragh, F. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02660-5 · Cited by 46
Wu, X., Song, M., Rakariyatham, K., Zheng, J., Wang, M., Xu, F., Gao, Z., & Xiao, H. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05156 · Cited by 44
CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
Kim, H. J., Zheng, M., Kim, S., Cho, J. J., Shin, C. H., Joe, Y., & Chung, H. (2011) · Immune Network · doi:10.4110/in.2011.11.6.376 · Cited by 46
Wang, Y., Zhang, X., Meng, F.-G., & Zeng, T. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1894624 · Cited by 40
Ying, Y.-T., Yang, J., Tan, X., Liu, R., Zhuang, Y., Xu, J.-X., & Ren, W. (2021) · Cells · doi:10.3390/cells10123426 · Cited by 40
Hristova, M., Spiess, P. C., Kasahara, D. I., Randall, M. J., Deng, B., & van der Vliet, A. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0134oc · Cited by 40
Ebihara, S., TAJIMA, H., & Ono, M. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1039-5 · Cited by 39
Yang, C., Zhang, C., Wang, Z., Tang, Z., Kuang, H., & Kong, A. T. (2016) · Molecules · doi:10.3390/molecules21080975 · Cited by 39
Huang, W., Liou, C., Shen, S., Hu, S., Chao, J. C.-J., Huang, C., & Wu, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111665 · Cited by 36
Transcription factor Nrf2 suppresses LPS-induced hyperactivation of BV-2 microglial cells
Koh, K., Kim, J., Jang, Y. J., Yoon, K., Cha, Y., Lee, H. J., & Kim, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.004 · Cited by 36
Sulfosuccinimidyl oleate sodium is neuroprotective and alleviates stroke-induced neuroinflammation
Dhungana, H., Huuskonen, M. T., Jaronen, M., Lemarchant, S., Ali, H., Keksa-Goldsteine, V., Goldsteins, G., Kanninen, K. M., Koıstınaho, J., & Malm, T. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1010-7 · Cited by 35
Ethyl gallate attenuates acute lung injury through Nrf2 signaling
Mehla, K., Balwani, S., Agrawal, A., & Ghosh, B. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.030 · Cited by 34
Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB
Yang, H. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i14.1680 · Cited by 34
Wang, L., Su, S., Wang, L., Zhang, G., Zhang, R., Niu, Y., Guo, Y., Li, C., Jiang, W., Liu, Y., et al. (2015) · Europe PMC (PubMed Central) · Cited by 34
High NRF2 expression controls endoplasmic reticulum stress induced apoptosis in multiple myeloma
Sun, Y., Aziz, A., Bowles, K. M., & Rushworth, S. A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.005 · Cited by 34
Self-citationAnwar‐Mohamed, A., Elshenawy, O. H., Soshilov, A. A., Denison, M. S., Le, X. C., Klotz, L., & El‐Kadi, A. O. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.810 · Cited by 33
Metadata
- Authors
- Rushworth, S. A., MacEwan, D. J., & O’Connell, M. A.
- Affiliations
- University of East Anglia (GB)
- School of Chemical Sciences and Pharmacy, University of East Anglia , Norwich,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11
- Volume
- 181
- Issue
- 10
- Pages
- 6730-6737
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC2923058
- OpenAlex
- W2105691693
- Cited by
- 215
- References
- 51
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 12 · 2023: 8 · 2022: 14 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 8 · 2017: 14 · 2016: 8 · 2015: 16 · 2014: 17 · 2013: 13 · 2012: 11
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- University of East Anglia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- lipopolysaccharide, NAD(P)H:quinone oxidoreductase 1, heme oxygenase-1, Nrf2, human monocytes, sepsis, inflammation, TNF-α, IL-1β, innate immunity
- MeSH terms
- Cell Line, Gene Expression Regulation, Humans, Inflammation, Lipopolysaccharides, Monocytes, RNA, Messenger, Tumor Necrosis Factor-alpha, Gene Expression, NAD(P)H Dehydrogenase (Quinone), Reactive Oxygen Species, Sepsis, Reverse Transcriptase Polymerase Chain Reaction, Gene Silencing, NF-E2-Related Factor 2, Heme Oxygenase-1, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review